NYSE : A
Agilent Technologies, Inc. — Key statistics
Healthcare · Diagnostics & Research · United States
Last price 181.15 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 51.07B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 49.30B |
| Enterprise Value | 51.69B |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 23, 2026 |
| Ex-Dividend Date | Oct 6, 2026 |
Shares
| Measure | Value |
|---|
| Current Share Class | 281.93M |
| Shares Outstanding | 281.93M |
| Shares Change (YoY) | -0.53% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 0.16% |
| Owned by Institutions (%) | 94.01% |
| Float | 281.23M |
Ratios
| Measure | Value |
|---|
| PE Ratio | 34.48 |
| Forward PE | 26.61 |
| PS Ratio | 6.69 |
| Forward PS | 6.26 |
| PB Ratio | 6.70 |
| P/TBV Ratio | 34.55 |
| P/FCF Ratio | 38.91 |
| P/OCF Ratio | 30.64 |
| PEG Ratio | 2.64 |
Evratios
| Measure | Value |
|---|
| EV / Earnings | 35.90 |
| EV / Sales | 7.01 |
| EV / EBITDA | 24.85 |
| EV / EBIT | 28.57 |
| EV / FCF | 40.80 |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 2.05 |
| Quick Ratio | 1.41 |
| Debt / Equity | 0.56 |
| Debt / EBITDA | 1.95 |
| Debt / FCF | 3.27 |
| Interest Coverage | 17.07 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | 20.97% |
| Return on Assets (ROA) | 8.63% |
| Return on Invested Capital (ROIC) | 16.89% |
| Return on Capital Employed (ROCE) | 15.49% |
| Weighted Average Cost of Capital (WACC) | 10.22% |
| Revenue Per Employee | $405,055 |
| Profits Per Employee | $79,121 |
| Employee Count | 18,200 |
| Asset Turnover | 0.56 |
| Inventory Turnover | 3.21 |
Taxes
| Measure | Value |
|---|
| Income Tax | 218.00M |
| Effective Tax Rate | 13.15% |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 1.21 |
| 52-Week Price Change | +22.12% |
| 50-Day Moving Average | 164.09 |
| 200-Day Moving Average | 136.06 |
| Relative Strength Index (RSI) | 54.91 |
| Average Volume (20 Days) | 2,081,049 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 5.03M |
| Short Previous Month | 5.08M |
| Short % of Shares Out | 1.78% |
| Short % of Float | 1.79% |
| Short Ratio (days to cover) | 2.03 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 7.37B |
| Gross Profit | 3.96B |
| Operating Income | 1.81B |
| Pretax Income | 1.66B |
| Net Income | 1.44B |
| EBITDA | 2.08B |
| EBIT | 1.81B |
| Earnings Per Share (EPS) | $5.07 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 1.76B |
| Total Debt | 4.15B |
| Net Cash | -2.39B |
| Net Cash Per Share | -$8.48 |
| Equity (Book Value) | 7.36B |
| Book Value Per Share | 26.11 |
| Working Capital | 2.40B |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | 1.61B |
| Capital Expenditures | -342.00M |
| Depreciation & Amortization | 271.00M |
| Net Borrowing | 536.00M |
| Free Cash Flow | 1.27B |
| FCF Per Share | $4.49 |
Margins
| Measure | Value |
|---|
| Gross Margin | 53.65% |
| Operating Margin | 24.54% |
| Pretax Margin | 22.49% |
| Profit Margin | 19.53% |
| EBITDA Margin | 28.21% |
| EBIT Margin | 24.54% |
| FCF Margin | 17.19% |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | $1.02 |
| Dividend Yield | 0.58% |
| Dividend Growth (YoY) | 2.82% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 20.11% |
| FCF Payout Ratio | 22.70% |
| Buyback Yield | 0.53% |
| Shareholder Yield | 1.11% |
| Earnings Yield | 2.90% |
| FCF Yield | 2.57% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $182.05 |
| Price Target Difference | 4.11% |
| Analyst Consensus | Buy |
| Analyst Count | 22 |
| Revenue Growth Forecast (3Y) | 7.04% |
| EPS Growth Forecast (3Y) | 10.14% |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 4.69 |
| Piotroski F-Score | 5 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |